3p would include TGFBR2, CNTN4, and CHL1 (reported for colorectal cancer) and CNTN6 (for breast cancer [63]), as well as FHIT, ROBO1-GRE1 and SETMAR-LRRN1. This evidence concerns the gene CHL1 and breast carcinoma.